Andrew Elbardissi

Andrew ElBardissi, MD, is a Partner at Deerfield Management since January 2017 and holds several board member positions at various companies, including Medical Microinstruments, Inc., Aurion Biotech, Bitteroot, Adela Bio, Encodia, Inc., Endologix LLC, Sema4, Reprieve Cardiovascular, and Element Science, Inc. Andrew possesses advanced educational credentials, including an MBA from Harvard Business School, an MPH in Quantitative Methods from Harvard T.H. Chan School of Public Health, and a Doctor of Medicine degree from Mayo Clinic Alix School of Medicine.